Abstract
Revised guidelines for the management of atrial fibrillation include new sections on dronedarone and aspirin–clopidogrel therapy, but dabigatran treatment is slated for an upcoming partial revision, according to the document.[1][1] The document was developed for the American College of Cardiology
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have